Live in Care

Heart failure drug could cut deaths by a fifth

A new drug believed to cause a 20 per cent reduction in heart failure deaths could present a 'major advance' in treatment. The drug, LCZ696, helps improve blood flow in heart failure patients. Heart failure is a syndrome caused by the heart not working properly, which can make people vulnerable to serious complications. A new study compared LCZ696 with an existing heart failure drug called enalapril, which is also used to treat high blood pressure.

Researchers found that LCZ696 is better than enalapril for preventing death from cardiovascular causes and for preventing hospitalisation for heart failure. The results were so striking that they decided to halt the trial.

The Independent, 1st September 2014

Is immunotherapy the answer to MS? The Good Care Group strengthens its team with specialist nurse, Penny Hibberd
comments powered by Disqus
Request a
Call